A new study shows that tasimelteon, an insomnia medication, can help improve sleep in shift workers and those suffering from jetlag.
According to the study published in the Lancet, tasimelteon (VEC-162) stimulates the production of the sleep hormone melatonin, and therefore helps individuals experience a longer and deeper sleep.
Findings revealed that tasimelteon tackles the transient insomnia commonly reported among individuals suffering from circadian rhythm disorders, such as people affected by jetlag, shift workers, airline crew, and tourists.
The study showed that the medication directly affects the sleep-wake cycle, and therefore helps individuals fall asleep faster, have a better sleep and wake up faster.
No significant side effect, however, were reported following the use of the drug.
Circadian rhythm disorders are the common cause of insomnia in individuals whose activities do not follow the internal body clock. The condition is characterized by inability to fall asleep and feeling sleepy when trying to remain awake.
PKH/HGH